Davis Polk advised the underwriters in connection with an initial public offering of 7,500,000 shares of common stock of Deciphera Pharmaceuticals, Inc., at $17.00 per share, for total…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by ViaSat, Inc. of $700 million aggregate principal amount of its…
Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $1 billion aggregate principal amount of its 1.850% senior notes due 2020, under its $40 billion medium…
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc. of $750 million aggregate principal amount of its 3.000% senior…
Davis Polk advised the underwriters in connection with the offering of C$500 million aggregate principal amount of 1.800% Canadian dollar bonds due 2022 issued by Export Development…
Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by Enova International, Inc. of $250 million aggregate principal amount of 8.500%…
Davis Polk advised DXC Technology Company on its SEC-registered offering of $650 million aggregate principal amount of senior floating-rate notes due 2021.
DXC is an end-to-end IT…
Davis Polk advised the sole underwriter in connection with the SEC-registered secondary offering of 5,000,000 Class A ordinary shares of Manchester United plc by its shareholder, Red…
Davis Polk advised DXC Technology Company in connection with its registered exchange offers of (i) up to $445.265 million aggregate principal amount of DXC’s new 4.45% senior notes due 2022…
Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by AK Steel Corporation, a wholly owned subsidiary of…